Cargando…

High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research

The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda startin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Felix H, Lewith, George, Witt, Claudia M, Linde, Klaus, von Ammon, Klaus, Cardini, Francesco, Falkenberg, Torkel, Fønnebø, Vinjar, Johannessen, Helle, Reiter, Bettina, Uehleke, Bernhard, Weidenhammer, Wolfgang, Brinkhaus, Benno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931324/
https://www.ncbi.nlm.nih.gov/pubmed/24499316
http://dx.doi.org/10.1186/1472-6882-14-46
_version_ 1782304642932146176
author Fischer, Felix H
Lewith, George
Witt, Claudia M
Linde, Klaus
von Ammon, Klaus
Cardini, Francesco
Falkenberg, Torkel
Fønnebø, Vinjar
Johannessen, Helle
Reiter, Bettina
Uehleke, Bernhard
Weidenhammer, Wolfgang
Brinkhaus, Benno
author_facet Fischer, Felix H
Lewith, George
Witt, Claudia M
Linde, Klaus
von Ammon, Klaus
Cardini, Francesco
Falkenberg, Torkel
Fønnebø, Vinjar
Johannessen, Helle
Reiter, Bettina
Uehleke, Bernhard
Weidenhammer, Wolfgang
Brinkhaus, Benno
author_sort Fischer, Felix H
collection PubMed
description The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens’ needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public’s health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges.
format Online
Article
Text
id pubmed-3931324
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39313242014-02-22 High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research Fischer, Felix H Lewith, George Witt, Claudia M Linde, Klaus von Ammon, Klaus Cardini, Francesco Falkenberg, Torkel Fønnebø, Vinjar Johannessen, Helle Reiter, Bettina Uehleke, Bernhard Weidenhammer, Wolfgang Brinkhaus, Benno BMC Complement Altern Med Correspondence The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens’ needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public’s health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges. BioMed Central 2014-02-06 /pmc/articles/PMC3931324/ /pubmed/24499316 http://dx.doi.org/10.1186/1472-6882-14-46 Text en Copyright © 2014 Fischer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Fischer, Felix H
Lewith, George
Witt, Claudia M
Linde, Klaus
von Ammon, Klaus
Cardini, Francesco
Falkenberg, Torkel
Fønnebø, Vinjar
Johannessen, Helle
Reiter, Bettina
Uehleke, Bernhard
Weidenhammer, Wolfgang
Brinkhaus, Benno
High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title_full High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title_fullStr High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title_full_unstemmed High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title_short High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
title_sort high prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931324/
https://www.ncbi.nlm.nih.gov/pubmed/24499316
http://dx.doi.org/10.1186/1472-6882-14-46
work_keys_str_mv AT fischerfelixh highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT lewithgeorge highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT wittclaudiam highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT lindeklaus highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT vonammonklaus highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT cardinifrancesco highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT falkenbergtorkel highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT fønnebøvinjar highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT johannessenhelle highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT reiterbettina highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT uehlekebernhard highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT weidenhammerwolfgang highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch
AT brinkhausbenno highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch